Cargando…
Potential Association of Cytochrome P450 Copy Number Alteration in Tumour with Chemotherapy Resistance in Lung Adenocarcinoma Patients
Resistance to anticancer agents is a major obstacle to efficacious tumour therapy and responsible for high cancer-related mortality rates. Some resistance mechanisms are associated with pharmacokinetic variability in anticancer drug exposure due to genetic polymorphisms of drug-metabolizing cytochro...
Autores principales: | Incze, Evelyn, Mangó, Katalin, Fekete, Ferenc, Kiss, Ádám Ferenc, Póti, Ádám, Harkó, Tünde, Moldvay, Judit, Szüts, Dávid, Monostory, Katalin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487787/ https://www.ncbi.nlm.nih.gov/pubmed/37686184 http://dx.doi.org/10.3390/ijms241713380 |
Ejemplares similares
-
Impact of genetic and non-genetic factors on hepatic CYP2C9 expression and activity in Hungarian subjects
por: Fekete, Ferenc, et al.
Publicado: (2021) -
CYP2B6 allelic variants and non-genetic factors influence CYP2B6 enzyme function
por: Mangó, Katalin, et al.
Publicado: (2022) -
End-stage renal disease reduces the expression of drug-metabolizing cytochrome P450s
por: Déri, Máté Tamás, et al.
Publicado: (2020) -
CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients
por: Déri, Máté, et al.
Publicado: (2021) -
CYP1A2 mRNA Expression Rather than Genetic Variants Indicate Hepatic CYP1A2 Activity
por: Fekete, Ferenc, et al.
Publicado: (2022)